Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Click here to be automatically notified when we publish a stock exchange announcement.
Key information
2020 Third quarter results announcement
We will announce our third quarter 2020 results at 12:00 GMT, 08:00 EDT on Wednesday 28 October.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, Iain Mackay, CFO, and Luke Miels, President, Global Pharmaceuticals, at 14:00 GMT, 10:00 EDT.
Press releases for media
- ViiV Healthcare presents continued positive findings from first-ever implementation science study on integrating an investigational once-monthly injectable HIV treatment into US healthcare practices
- ViiV Healthcare presents positive new findings from two studies of its investigational, long-acting regimen of cabotegravir and rilpivirine, including five-year data showing long-term durability, efficacy, safety, and tolerability
- ViiV Healthcare announces analysis showing no antiretroviral therapy interruptions due to COVID-19 across its clinical development programme for investigational, long-acting cabotegravir and rilpivirine
- GSK presents positive clinical data on maternal and older adults RSV candidate vaccines
GSK Twitter
-
GSK @GSK
From accelerating vaccine development to machine learning in gene signatures, our scientists are taking part in exciting vaccines discussions at the #WVCUSA. Read more about how we innovate in vaccines gsk.com/en-gb/behind-t…
about 25 days ago -
GSK @GSK
Hear from our GSK experts in cancer R&D about new research in immuno-oncology (IO) and how it could potentially help more patients in @NatureCustom gsk.to/3l0TGX8
about 25 days ago
